357 related articles for article (PubMed ID: 29181334)
1. Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells.
Hemmati S; Haque T; Gritsman K
Front Oncol; 2017; 7():265. PubMed ID: 29181334
[TBL] [Abstract][Full Text] [Related]
2. Recreating the Bone Marrow Microenvironment to Model Leukemic Stem Cell Quiescence.
O'Reilly E; Zeinabad HA; Nolan C; Sefy J; Williams T; Tarunina M; Hernandez D; Choo Y; Szegezdi E
Front Cell Dev Biol; 2021; 9():662868. PubMed ID: 34589478
[TBL] [Abstract][Full Text] [Related]
3. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
4. Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia.
Corces MR; Chang HY; Majeti R
Front Oncol; 2017; 7():263. PubMed ID: 29164062
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndrome hematopoietic stem cell.
Li J
Int J Cancer; 2013 Aug; 133(3):525-33. PubMed ID: 23047726
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
[TBL] [Abstract][Full Text] [Related]
7. Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
Martiáñez Canales T; de Leeuw DC; Vermue E; Ossenkoppele GJ; Smit L
Cancers (Basel); 2017 Jun; 9(7):. PubMed ID: 28665351
[TBL] [Abstract][Full Text] [Related]
8. Preleukemic stem cells: leave it or not?
Su M; Cheng H; Cheng T
Blood Sci; 2020 Apr; 2(2):54-58. PubMed ID: 35402817
[TBL] [Abstract][Full Text] [Related]
9. Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells.
Majeti R; Jamieson C; Pang WW; Jaiswal S; Leeper NJ; Wernig G; Weissman IL
Annu Rev Med; 2022 Jan; 73():307-320. PubMed ID: 35084991
[TBL] [Abstract][Full Text] [Related]
10. DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells.
Zhang W; Wang G; Liang A
Adv Exp Med Biol; 2019; 1143():147-171. PubMed ID: 31338819
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
12. Promotion of Expansion and Differentiation of Hematopoietic Stem Cells by Interleukin-27 into Myeloid Progenitors to Control Infection in Emergency Myelopoiesis.
Furusawa J; Mizoguchi I; Chiba Y; Hisada M; Kobayashi F; Yoshida H; Nakae S; Tsuchida A; Matsumoto T; Ema H; Mizuguchi J; Yoshimoto T
PLoS Pathog; 2016 Mar; 12(3):e1005507. PubMed ID: 26991425
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of bone marrow culture.
Moore MA
Hamatol Bluttransfus; 1976; 19():79-90. PubMed ID: 795748
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies.
Warr MR; Pietras EM; Passegué E
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(6):681-701. PubMed ID: 21412991
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hematopoietic stem cell activity by inflammation.
Schuettpelz LG; Link DC
Front Immunol; 2013; 4():204. PubMed ID: 23882270
[TBL] [Abstract][Full Text] [Related]
16. Targeting Immune Signaling Pathways in Clonal Hematopoiesis.
Azrakhsh NA; Mensah-Glanowska P; Sand K; Kittang AO
Curr Med Chem; 2019; 26(28):5262-5277. PubMed ID: 30907306
[TBL] [Abstract][Full Text] [Related]
17. Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases.
Chiba Y; Mizoguchi I; Hasegawa H; Ohashi M; Orii N; Nagai T; Sugahara M; Miyamoto Y; Xu M; Owaki T; Yoshimoto T
Cell Mol Life Sci; 2018 Apr; 75(8):1363-1376. PubMed ID: 29218601
[TBL] [Abstract][Full Text] [Related]
18. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
19. Clonal evolution of preleukemic hematopoietic stem cells in acute myeloid leukemia.
Sykes SM; Kokkaliaris KD; Milsom MD; Levine RL; Majeti R
Exp Hematol; 2015 Dec; 43(12):989-92. PubMed ID: 26455528
[TBL] [Abstract][Full Text] [Related]
20. IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
Verhagen HJMP; van Gils N; Martiañez T; van Rhenen A; Rutten A; Denkers F; de Leeuw DC; Smit MA; Tsui ML; de Vos Klootwijk LLE; Menezes RX; Çil M; Roemer MGM; Vermue E; Heukelom S; Zweegman S; Janssen JJWM; Ossenkoppele GJ; Schuurhuis GJ; Smit L
Cell Rep; 2018 Dec; 25(11):3021-3035.e5. PubMed ID: 30540936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
